Quentin Hill: Collaborative Progress in Immune Thrombocytopenia Drug Development
Quentin Hill, Consultant Haematologist at Leeds Teaching Hospitals NHS Trust, shared Caroline Voltz-Girolt‘s post on LinkedIn, adding:
“In 2014, the EMA published guidelines for the development of medicinal products intended for treatment of chronic ITP.
The workshop below is part of a workstream that will result in an update of those guidelines. Very grateful to the EMA for taking the perspectives of clinicians and expert patients into consideration, and looking forward to publication of this important update.
Thanks also to Caroline Voltz-Girolt for seamless organisation”
Caroline Voltz-Girolt, Senior Scientific Officer in Office of Advanced Therapies and Haemato-Oncology at European Medicines Agency, shared a post on LinkedIn:
“On 30 June 2026, EMA organised a workshop on the challenges in drug development, regulation and clinical practice in immune thrombocytopenia.
We had highly insightful discussions on this topic. A sincere thank you to all the speakers for their comprehensive presentations, thoughtful perspectives, and excellent contributions to the discussion.”
Stay updated with Hemostasis Today.
-
Nov 4, 2026, 03:51Riana Gjeta: Sharing Research on Blood Donor Safety in the Balkans
-
Nov 4, 2026, 03:48Umberto Pensato: World Stroke Congress – Science, Collaboration, and Recognition
-
Nov 4, 2026, 03:41Alejandro González Veliz: Understanding and Managing Stent Underexpansion
-
Nov 4, 2026, 03:26Violeta Jardin: The Evolution of Viscoelastic Testing
-
Nov 4, 2026, 03:12Daniele Sannipoli: Beyond Thrombosis Prevention in Polycythaemia Vera
-
Nov 4, 2026, 02:26Iris Paola Garcia Herrera: Antiphospholipid Antibodies in Children Beyond Thrombosis
-
Nov 4, 2026, 00:31Maria Cherska: Beyond LDL – Remnant Cholesterol and Stroke Prognosis
-
Nov 3, 2026, 22:00Ravi C Dara: What’s New in ASFA’s 10th Edition – Practical Updates for the Apheresis Clinician
-
Nov 3, 2026, 21:46Cedric Hermans: Treatment Differentiators for Shared Decision-Making in Haemophilia in 2026